CN202751490U

CN202751490U - Chemotherapy toxic and side effect protective device

Info

Publication number: CN202751490U
Application number: CN 201220394503
Authority: CN
Inventors: 张述
Original assignee: Individual
Current assignee: Individual
Priority date: 2012-08-10
Filing date: 2012-08-10
Publication date: 2013-02-27
Anticipated expiration: 2022-08-10

Abstract

The utility model discloses a chemotherapy toxic and side effect protective device which comprises a refrigerating unit and at least one ice cap. The refrigerating unit is connected with the any ice cap through a hosepipe. The chemotherapy toxic and side effect protective device further comprises at least a pair of ice gloves and at least a pair of ice socks. Any one pair of ice gloves and any one pair of ice socks are connected with the refrigerating unit through the hosepipes. The chemotherapy toxic and side effect protective device not only has the function of preventing hair loss, but also has a protective effect for nerve endings.

Description

A kind of chemical therapy toxic side effect protector

Technical field

This utility model relates to a kind of medical apparatus and instruments, refers to especially a kind of for the post-reacted chemical therapy toxic side effect protector of prophylaxis of tumours chemotherapy of patients.

Background technology

At present, tumor is the principal disease of harm humans health, and chemotherapy is one of main means for the treatment of tumor, although chemotherapy can start good therapeutic effect, usually can produce toxic and side effects behind the chemotherapy of tumors, such as alopecia, numb limbs and tense tendons etc.

Thereby the reason of hair losing by chemical therapy is to cause alopecia because the chemotherapeutics that arrives head with blood circulation has destroyed the hair growth promoting tissue of skin of head, in order to prevent this class patient alopecia, except the minimizing dosage or stop the chemotherapy, there is no effective way.Numb limbs and tense tendons then is because chemotherapeutics arrives the human limb end with blood circulation, causes the peripheral nerve damage, causes the symptom of limbs of patient numbness.

Hospital adopts Medical ice cap anti-loss now, and Medical ice cap is the structural principle by electric refrigerator, and through the Medical head Local physical cooling apparatus of innovation, therefore, it only has anti-loss effect.In addition, existing Medical ice cap shell all is hard, and the patient can only be seated and treat, and in the time of patient's recumbency, using can be very uncomfortable.

The utility model content

This utility model provides a kind of chemical therapy toxic side effect protector of practicability and effectiveness, the problems referred to above that exist to solve prior art.The chemical therapy toxic side effect protector that this utility model provides not only has anti-loss function, also has simultaneously the teleneuron protective effect.

The technical solution of the utility model is as follows:

A kind of chemical therapy toxic side effect protector; comprise refrigerating plant and the ice cap of at least one; all be connected to each other by flexible pipe between described refrigerating plant and the arbitrary ice cap; it is characterized in that: also comprise the freezing cold cover of at least one pair and the ice socks of at least one pair, the freezing cold cover of described arbitrary pair and arbitrary secondary ice socks are all equally by hose connection described refrigerating plant.

So; the freezing cold cover and the ice socks that are in low temperature state can make the tip tiny blood vessels shrink, and then enter the Oligemia of tip tiny blood vessels, reduce so that chemotherapeutics arrives the concentration of limb end; thereby the damage of protection peripheral nerve, the symptom of reduction limbs of patient numbness.In like manner, the ice cap that is in low temperature state also can be so that chemotherapeutics arrives the concentration of scalp to be reduced, and then the protection hair follicle, anti-loss.

As improvement of the present utility model, described ice cap comprises soft inner liner and soft external thermal insulation, and the lower lip of described ice cap then is equipped with bandage.

As improvement of the present utility model, described inner liner is spongy layer; Described external thermal insulation is the heat insulation foam layer.

As further improvement of the utility model, described inner liner is the bafta layer; Described external thermal insulation is the heat insulation foam layer.

As further improvement of the utility model, described chemical therapy toxic side effect protector also comprises interconnective temperature control equipment and temperature sensor, and described temperature control equipment connects refrigerating plant, and described temperature sensor is installed on the ice cap inboard.

Further improve as of the present utility model, the ring-type aeration ring for pressurization is installed in the described ice cap, the diameter of this ring-type aeration ring is 2cm～4cm.

Be compared with existing technology to description of the present utility model as can be known by above-mentioned, the utility model has the advantage of:

1, in the chemical therapy toxic side effect protector that this utility model provides, ice cap and freezing cold cover, ice socks are used in conjunction with, and can reduce the peripheral blood circulation of Whole Body, and therefore, it not only has anti-loss function, also has simultaneously the teleneuron protective effect.

2, in the chemical therapy toxic side effect protector of the present utility model, the inside and outside two-layer of ice cap all is that soft material is made, and when the patient had on ice cap and lies down, head there is no foreign body sensation, and it uses comparatively comfortable; In addition, by fixing of bandage, can make ice cap firmly be fixed in human body head, even when turn-over bed for patient, also there is not the possibility that comes off.

3, this utility model is responded to temperature in the ice cap immediately by temperature sensor, and by temperature control equipment the temperature of refrigerating plant accurately is controlled at 5 ℃～8 ℃, by above-mentioned mode, effectively reduce scalp circulation volume, the chemotherapeutics amount that enters like this scalp will greatly reduce, thereby alleviate even avoid chemotherapeutics to the damage of hair growth promoting tissue, reach the purpose of pre-Anti-hair loss.

When 4, using, inflatable pressurized in the ring-type aeration ring is surrounded on human body head tightly to guarantee the ring-type aeration ring, and the blood vessel of compressing head, effectively reduces scalp circulation volume, so just can further reach the purpose of pre-Anti-hair loss.

Description of drawings

Fig. 1 is structural representation of the present utility model.

Fig. 2 is the upward view of this ice cap.

The specific embodiment

The specific embodiment of the present utility model is described with reference to the accompanying drawings.

Embodiment one

With reference to Fig. 1, a kind of chemical therapy toxic side effect protector comprises an ice cap 10, a secondary freezing cold cover 11, secondary ice socks 12 and a refrigerating plant 2, and refrigerating plant 2 connects ice cap 10 freezing cold covers 11 and ice socks 12 with the flexible pipe 3 that is connected bifurcated.

During use, the cold air of refrigerating plant 2 enters in ice cap 10, freezing cold cover 11 and the ice socks 12 by flexible pipe 3.Ice cap 10 is used in conjunction with freezing cold cover 11 and ice socks 12, can reduce the Whole Body peripheral blood circulation, and therefore, it not only has anti-loss function, also has simultaneously the teleneuron protective effect.

With reference to Fig. 2, the chemical therapy toxic side effect protector also comprises interconnective temperature control equipment (not shown in FIG.) and temperature sensor 4 simultaneously, and temperature control equipment connects refrigerating plant 2, and temperature sensor 4 is installed in the ice cap 10.Like this, temperature sensor 4 can immediately be sensed the temperature of human body head and the instant messages of temperature is fed back to temperature control equipment, then refrigerating plant 2 is regulated by temperature control equipment more again, makes its temperature be controlled at 5 ℃～8 ℃.

Certainly, also temperature sensor 4 can be arranged in freezing cold cover 11 and the ice socks 12, like this, temperature sensor 4 can immediately be sensed the temperature of human limb and the instant messages of temperature is fed back to temperature control equipment, then again refrigerating plant 2 is regulated by temperature control equipment again, made its temperature be controlled at 5 ℃～8 ℃.

Three control panel 6(of temperature control equipment control respectively ice cap 10, freezing cold cover 11 and ice socks 12) be arranged on the shell of refrigerating plant 2.

Continue to see figures.1.and.2, ice cap 10 comprises that soft spongy layer 101(also can be substituted by other soft material, such as bafta) and soft heat insulation foam layer 102, the lower lip of described ice cap 10 then is equipped with bandage 103.Ring-type aeration ring 5 is installed on the spongy layer 101, the diameter of this ring-type aeration ring 5 is 2cm～4cm, during use, ring-type aeration ring 5 interior inflatable pressurizeds, to guarantee that ring-type aeration ring 5 is surrounded on human body head tightly, and the blood vessel of compressing head, effectively reduce scalp circulation volume, so just can further reach the purpose of pre-Anti-hair loss.

Above-mentioned only is the specific embodiment of the present utility model, but design concept of the present utility model is not limited to this, allly utilizes this design that this utility model is carried out the change of unsubstantiality, all should belong to the behavior of invading this utility model protection domain.

Claims

1. chemical therapy toxic side effect protector; comprise refrigerating plant and the ice cap of at least one; all be connected to each other by flexible pipe between described refrigerating plant and the arbitrary ice cap; it is characterized in that: also comprise the freezing cold cover of at least one pair and the ice socks of at least one pair, the freezing cold cover of described arbitrary pair and arbitrary secondary ice socks are all equally by hose connection described refrigerating plant.

2. a kind of chemical therapy toxic side effect protector as claimed in claim 1, it is characterized in that: described ice cap comprises soft inner liner and soft external thermal insulation, and the lower lip of described ice cap then is equipped with bandage.

3. a kind of chemical therapy toxic side effect protector as claimed in claim 2, it is characterized in that: described inner liner is spongy layer; Described external thermal insulation is the heat insulation foam layer.

4. a kind of chemical therapy toxic side effect protector as claimed in claim 2, it is characterized in that: described inner liner is the bafta layer; Described external thermal insulation is the heat insulation foam layer.

5. a kind of chemical therapy toxic side effect protector as claimed in claim 1; it is characterized in that: described chemical therapy toxic side effect protector also comprises interconnective temperature control equipment and temperature sensor; described temperature control equipment connects refrigerating plant, and described temperature sensor is installed on the ice cap inboard.

6. a kind of chemical therapy toxic side effect protector as claimed in claim 1 is characterized in that: the ring-type aeration ring for pressurization is installed in the described ice cap, and the diameter of this ring-type aeration ring is 2cm～4cm.